119.02
                                            
                                Panoramica
                                Notizia
                                Cronologia dei prezzi
                                    Catena di opzioni
                                Financials
                                    Perché DVA Giù?
                                Forum
                                Previsione
                                    Frazionamento azionario
                        
                        Precedente Chiudi:
              $118.75
            Aprire:
              $118.34
            Volume 24 ore:
                1.37M
            Relative Volume:
              1.67
            Capitalizzazione di mercato:
                $8.51B
            Reddito:
              $12.82B
            Utile/perdita netta:
              $936.34M
            Rapporto P/E:
              11.08
            EPS:
                10.74
            Flusso di cassa netto:
                $1.47B
            1 W Prestazione:
              -7.87%
            1M Prestazione:
              -10.42%
            6M Prestazione:
                -15.92%
            1 anno Prestazione:
              -14.87%
            Davita Inc Stock (DVA) Company Profile
Nome
                  
                      Davita Inc
                    
                Settore
                  Industria
                  Telefono
                  
                      310-536-2668
                    
                Indirizzo
                  
                      2000 16TH STREET, DENVER, CO
                    
                Confronta DVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                DVA
                            
                             Davita Inc | 119.02 | 8.38B | 12.82B | 936.34M | 1.47B | 10.74 | 
|   
                          
                                HCA
                            
                             Hca Healthcare Inc | 459.68 | 109.23B | 74.37B | 7.31B | 8.10B | 25.88 | 
|   
                          
                                THC
                            
                             Tenet Healthcare Corp | 206.49 | 18.33B | 20.69B | 2.40B | 1.55B | 15.62 | 
|   
                          
                                FMS
                            
                             Fresenius Medical Care Ag Adr | 26.84 | 15.66B | 21.23B | 924.30M | 2.22B | 1.2272 | 
|   
                          
                                UHS
                            
                             Universal Health Services Inc | 217.01 | 13.92B | 16.08B | 1.20B | 1.06B | 17.82 | 
|   
                          
                                EHC
                            
                             Encompass Health Corp | 113.85 | 11.77B | 5.51B | 494.70M | 386.40M | 4.84 | 
Davita Inc Stock (DVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione | 
|---|---|---|---|
| 2024-03-06 | Iniziato | Barclays | Equal Weight | 
| 2023-08-07 | Aggiornamento | UBS | Neutral → Buy | 
| 2022-11-01 | Downgrade | Deutsche Bank | Buy → Hold | 
| 2022-10-31 | Downgrade | UBS | Buy → Neutral | 
| 2022-08-19 | Ripresa | UBS | Buy | 
| 2022-06-21 | Reiterato | BofA Securities | Underperform | 
| 2021-09-10 | Iniziato | Cowen | Market Perform | 
| 2021-08-12 | Downgrade | Barclays | Overweight → Equal Weight | 
| 2021-03-26 | Downgrade | BofA Securities | Neutral → Underperform | 
| 2021-01-05 | Downgrade | BofA Securities | Buy → Neutral | 
| 2020-01-24 | Aggiornamento | Goldman | Neutral → Buy | 
| 2019-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform | 
| 2019-10-25 | Downgrade | Wolfe Research | Outperform → Peer Perform | 
| 2019-09-11 | Downgrade | William Blair | Outperform → Mkt Perform | 
| 2019-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral | 
| 2019-01-08 | Aggiornamento | UBS | Sell → Neutral | 
| 2019-01-03 | Iniziato | Deutsche Bank | Buy | 
| 2018-12-14 | Iniziato | Barclays | Overweight | 
| 2018-11-28 | Aggiornamento | Raymond James | Mkt Perform → Outperform | 
| 2018-11-16 | Iniziato | UBS | Sell | 
| 2018-11-08 | Downgrade | Raymond James | Strong Buy → Mkt Perform | 
| 2018-09-13 | Aggiornamento | JP Morgan | Underweight → Neutral | 
| 2018-01-04 | Aggiornamento | BofA/Merrill | Neutral → Buy | 
| 2017-12-12 | Aggiornamento | Robert W. Baird | Neutral → Outperform | 
| 2017-12-11 | Aggiornamento | Citigroup | Neutral → Buy | 
| 2017-12-07 | Aggiornamento | Raymond James | Outperform → Strong Buy | 
| 2017-11-08 | Reiterato | RBC Capital Mkts | Sector Perform | 
| 2017-10-09 | Downgrade | JP Morgan | Neutral → Underweight | 
| 2017-06-26 | Downgrade | Jefferies | Buy → Hold | 
| 2016-12-13 | Downgrade | Robert W. Baird | Outperform → Neutral | 
                    Mostra tutto
                     
                  
                Davita Inc Borsa (DVA) Ultime notizie
DaVita (NYSE:DVA) Sets New 52-Week Low After Earnings Miss - MarketBeat
Can DaVita Inc. stock beat market expectations this quarterQuarterly Risk Review & Free Real-Time Market Sentiment Alerts - newser.com
Is a relief rally coming for DaVita Inc. holdersPortfolio Value Summary & Weekly Setup with High ROI Potential - newser.com
Custom strategy builders for tracking DaVita Inc.Quarterly Portfolio Review & Technical Analysis for Trade Confirmation - newser.com
Will DaVita Inc. stock outperform tech sector in 2025July 2025 Summary & Safe Capital Preservation Plans - newser.com
How to integrate DaVita Inc. into portfolio analysis toolsTrade Risk Summary & Weekly Top Gainers Trade List - newser.com
Will DaVita Inc. rebound enough to break evenJuly 2025 Trade Ideas & Entry Point Confirmation Signals - newser.com
DaVita (NYSE:DVA) Releases FY 2025 Earnings Guidance - MarketBeat
Berkshire Hathaway Reduces Stake in DaVita (DVA) by $54.3 Millio - GuruFocus
DaVita (NYSE:DVA) Posts Earnings Results, Misses Expectations By $0.66 EPS - MarketBeat
DaVita Inc (DVA) Q3 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges - GuruFocus
DaVita Stock Down Post Q3 Earnings Miss Estimates, Revenues Up Y/Y - TradingView
Barclays Adjusts Price Target for DaVita (DVA), Maintains Equal-Weight Rating | DVA Stock News - GuruFocus
Barclays Adjusts Price Target on DaVita to $143 From $149 - MarketScreener
Deutsche Bank Adjusts Price Target on DaVita to $126 From $137 - MarketScreener
Davita Healthcare Partners stock hits 52-week low at $122.91 By Investing.com - Investing.com Nigeria
DaVita price target lowered to $143 from $149 at Barclays - TipRanks
DaVita Inc. (NYSE:DVA) Q3 2025 Earnings Call Transcript - Insider Monkey
Is DaVita Inc. stock bottoming outJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
Nisa Investment Advisors LLC Cuts Stock Position in DaVita Inc. $DVA - MarketBeat
Is DaVita Inc. stock safe for conservative investors2025 Top Gainers & Trade Opportunity Analysis - newser.com
Sumitomo Mitsui Trust Group Inc. Grows Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc. Reports Steady Q3 2025 Performance - TipRanks
Decoding DaVita Inc (DVA): A Strategic SWOT Insight - GuruFocus
DaVita HealthCare: Q3 Earnings Snapshot - Stamford Advocate
DaVita (DVA) Q3 2025 Earnings Call Transcript - Fortune
DaVita’s Profit Misses Mark As Costs And Volume Drop Bite - Finimize
DaVita (DVA) Reaffirms Full-Year Guidance Despite Challenges - GuruFocus
DaVita Delivers Steady Growth But Misses On Earnings - Finimize
Davita shares fall on weak earnings, Berkshire cuts stake further By Investing.com - Investing.com Canada
DaVita Q3 2025 Earnings: Revenue Up 4.8%, EPS Misses EstimatesNews and Statistics - IndexBox
DaVita misses quarterly profit estimates on rising costs, lower volumes - TradingView
DaVita (NYSE:DVA) Reports Q3 In Line With Expectations - TradingView
DaVita HealthCare (DVA) Q3 Earnings Lag Estimates - Yahoo Finance
DAVITA INC. SEC 10-Q Report - TradingView
DaVita Inc Reports Q3 Earnings: EPS of $2.04 Misses Estimates, R - GuruFocus
DaVita (DVA) Reports Q3 Revenue Slightly Below Expectations - GuruFocus
Healthcare provider DaVita's Q3 revenue rises 4.8% - MarketScreener
DaVita misses Q3 earnings estimates, maintains full-year outlook By Investing.com - Investing.com UK
Earnings Flash (DVA) DaVita Inc. Reports Q3 Revenue $3.42B, vs. FactSet Est of $3.435B - MarketScreener
DaVita misses Q3 earnings estimates, maintains full-year outlook - Investing.com
Earnings Flash (DVA) DaVita Inc. Posts Q3 Adjusted EPS $2.51 per Share, vs. FactSet Est of $3.22 - MarketScreener
DaVita Inc. 3rd Quarter 2025 Results - Lompoc Record
DaVita Inc. (NYSE:DVA) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Can DaVita Inc. (TRL) stock attract ESG investmentsEarnings Summary Report & Consistent Income Trade Recommendations - newser.com
Is DaVita Inc. stock gaining market share2025 Sector Review & Risk Managed Investment Strategies - Fundação Cultural do Pará
Truist Lowers PT on DaVita Inc. (DVA), Keeps a Hold Rating - MSN
Can Technology and Cost Discipline Lift DaVita's Q3 Earnings? - Nasdaq
AustralianSuper Pty Ltd Buys 57,937 Shares of DaVita Inc. $DVA - MarketBeat
Will DaVita Inc. stock profit from fiscal stimulusNew Guidance & Expert Approved Momentum Trade Ideas - newser.com
Is DaVita Inc. stock trading at a premium valuationJuly 2025 Decliners & Momentum Based Trading Signals - newser.com
Davita Inc Azioni (DVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):
                 
            
         
                     
                             Scarica l'app Stockscreener
                    Scarica l'app Stockscreener